Invega Sustenna Injection 75mg - Long Acting Antipsychotic for Schizophrenia

Invega Sustenna Injection 75mg

Invega Sustenna is a long-acting injectable antipsychotic medication designed for the treatment of schizophrenia in adults. This formulation of paliperidone palmitate offers a convenient once-monthly dosing schedule, helping to improve adherence and manage symptoms effectively.

• Long-acting formulation for monthly administration
• Effective in managing symptoms of schizophrenia
• Administered via intramuscular injection

• Active Ingredient Paliperidone Palmitate
• Dosage 75mg
• Administration Intramuscular (IM)

Invega Sustenna is primarily used for the treatment of schizophrenia in adults, providing a long-term solution for symptom management.

Healthcare professionals prescribing antipsychotic treatments for adult patients with schizophrenia.

Invega Sustenna is developed by Janssen Pharmaceuticals, a leader in mental health treatments, known for their innovative solutions in antipsychotic medications.